This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Martin L. Lipson, MD; Joseph H. Holmes, MD; Philip P. Ellis, MD

Arch Ophthalmol. 1969;82(6):830-835.

Abstract
A total of 19 patients receiving topically administered echothiophate iodide for control of chronic open angle glaucoma were treated with orally administered pralidoxime chloride (Protopam) to determine which small doses would reverse cholinesterase levels. One group of ten patients received 4.5 gm of pralidoxime chloride in divided doses weekly for four weeks. A second group of nine patients received 10.5 gm in divided doses weekly for three weeks. No significant changes in intraocular tension or facility of outflow were noted after pralidoxime chloride therapy, but a significant rise in erythrocyte cholinesterase activity (0.07 delta pH units; P < 0.01) was demonstrated. No significant toxic signs were noted. Clinical ramifications are discussed.

Author Affiliations
Denver

From the Division of Ophthalmology (Drs. Lipson and Ellis) and the Department of Internal Medicine (Dr. Holmes), University of Colorado Medical Center, Denver.

Footnotes
Submitted for publication June 11, 1969.

Read before the Section on Ophthalmology at the 118th annual convention of the American Medical Association, New York, July 14, 1969.

Reprint requests to the Division of Ophthalmology, University of Colorado Medical Center, 4200 E Ninth Ave, Denver 80220 (Dr. Lipson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacology and Toxicology of Ophthalmic Drugs
Macri
Arch Ophthalmol 1970;84:532-545.